During the past decade, Edward Hospital/Cancer Center?Plainfield conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 12 clinical trials were completed, i.e. on average, 34.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Edward Hospital/Cancer Center?Plainfield" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "NRG Oncology" with 4 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Edward Hospital/Cancer Center?Plainfield" #1 collaborator was "National Cancer Institute (NCI)" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "German Breast Group" with 2 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Edward Hospital/Cancer Center?Plainfield" are "Breast Cancer" (6 trials), "Stage IB Breast Cancer" (3 trials), "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials), "Stage II Breast Cancer" (3 trials) and "Stage II Lung Non-Small Cell Cancer AJCC v7" (3 trials). Many other conditions were trialed in "Edward Hospital/Cancer Center?Plainfield" in a lesser frequency.

Most popular intervention types in "Edward Hospital/Cancer Center?Plainfield" are "Drug" (34 trials), "Other" (26 trials), "Procedure" (17 trials), "Biological" (13 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (14 trials), "Laboratory Biomarker Analysis" (11 trials), "Computed Tomography" (9 trials), "Biospecimen Collection" (8 trials) and "Carboplatin" (8 trials). Other intervention names were less common.

The vast majority of trials in "Edward Hospital/Cancer Center?Plainfield" are 35 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Edward Hospital/Cancer Center?Plainfield". undefined are not yet recruiting, 13 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Edward Hospital/Cancer Center?Plainfield, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Edward Hospital/Cancer Center?Plainfield, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".